No change
Create an alert
Stocks and Shares ISAObjective
The ARK Genomic Revolution UCITS ETF (the "Fund") is actively managed and invests primarily in global equity securities of companies involved in the genomic revolution. These are companies that are substantially focused on or benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments, improvements and advancements in genomics into their business, such as by offering new products or services that rely on genomic sequencing, analysis, synthesis or instrumentation.These companies may include ones across multiple sectors, such as healthcare, information technology, materials, energy and consumer discretionary. These companies may also develop, produce,manufacture or significantly rely on or enable bionic devices, bio inspired computing, bioinformatics, molecular medicine and agricultural biotechnology.
- Leverage -
- Currency hedgingNo